Clinical trials
Not yet recruiting Rhabdomyosarcoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fudan University | 1 |
| Power Life Sciences Inc. | 1 |
| Seattle Children's Hospital | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
| University of Rochester | 1 |
| Xinxin Zhang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rhabdomyosarcoma | 8 |
| Sarcoma, Ewing | 3 |
| Osteosarcoma | 2 |
| Sarcoma | 2 |
| Carcinoma, Hepatocellular | 1 |
| Endodermal Sinus Tumor | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Liposarcoma | 1 |
| Liver Neoplasms | 1 |
| Medulloblastoma | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.